Face is Fabulous! Vitiligo of the face has a good prognosis; 70-80% of cases can repigment with treatment.
Systemic CXCL 10 may be a predictive biomarker for vitiligo progression and treatment response.
20% of segmental vitiligo patients will go onto develop thyroid disease; screen these patients every 3 years.
